Investor Presentaiton

Overview CSL is a leading global biotech company that develops and delivers innovative biotherapies and influenza vaccines that save lives and help people with life-threatening medical conditions live full lives 60+ + Countries of operations around the world 4 | Driven by Our Promise™ US$8.5bn+ + in annual revenue (FY19) 8 Manufacturing sites across 6 countries + Australia China Germany Switzerland UK US Employees around the world 26,000+ US$3.3bn in R&D investments in the last 5 years advances exciting pipeline¹ 1,700+ A 257+ R&D employees Plasma collection centres across Europe and North America 1. FY15 to FY19 CSL

View entire presentation